Robert Mechera
Overview
Explore the profile of Robert Mechera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
43
Citations
784
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Novis E, Parikh R, Mechera R, Davey L, Garibotto N
Int J Surg Pathol
. 2024 Oct;
:10668969241286233.
PMID: 39360401
Lymphomas associated with breast implants are rare, and the majority of these are anaplastic large-cell lymphomas of T-cell origin. Very uncommonly B-cell lymphomas associated with implants have been described, and...
2.
Papachristos A, Nicholls L, Mechera R, Aniss A, Robinson B, Clifton-Bligh R, et al.
Oncologist
. 2023 Aug;
28(12):1064-1071.
PMID: 37632760
Background: There remains uncertainty regarding the optimal extent of initial surgery and management of recurrent disease in medullary thyroid cancer (MTC). We aim to describe the patterns of disease recurrence...
3.
Kesby N, Mechera R, Fuchs T, Papachristos A, Gild M, Tsang V, et al.
J Clin Endocrinol Metab
. 2023 Jun;
109(1):e437.
PMID: 37379017
No abstract available.
4.
Kesby N, Mechera R, Fuchs T, Papachristos A, Gild M, Tsang V, et al.
J Clin Endocrinol Metab
. 2023 Mar;
108(10):2626-2634.
PMID: 36964913
Context: Management of sporadic medullary thyroid microcarcinoma smaller than 1 cm (micro-MTC) is controversial because of conflicting reports of prognosis. As these cancers are often diagnosed incidentally, they pose a...
5.
Mechera R, Marechal-Ross I, Sidhu S, Campbell P, Sywak M
Surg Oncol Clin N Am
. 2023 Mar;
32(2):383-398.
PMID: 36925192
Lymph node metastasis in thyroid cancer is common and associated with an increased risk of locoregional recurrence (LRR). Although therapeutic central neck dissection is well established, prophylactic central node dissection...
6.
Vulin M, Jehanno C, Sethi A, Correia A, Obradovic M, Couto J, et al.
Oncogene
. 2022 Aug;
41(39):4459-4473.
PMID: 36008466
Plasticity delineates cancer subtypes with more or less favourable outcomes. In breast cancer, the subtype triple-negative lacks expression of major differentiation markers, e.g., estrogen receptor α (ERα), and its high...
7.
Chui J, Papachristos A, Mechera R, Sidhu S, Sywak M, Lee J, et al.
Br J Surg
. 2022 Aug;
109(11):1164-1171.
PMID: 35927948
Background: The mortality rate is low in endocrine surgery, making it a difficult outcome to use for quality improvement in individual units. Lessons from population data sets are of value...
8.
Staubli S, Kettelhack C, Oertli D, von Holzen U, Zingg U, Mattiello D, et al.
HPB (Oxford)
. 2022 Jul;
24(11):1898-1906.
PMID: 35817694
Background: This is the first randomized trial to evaluate the efficacy of intraoperative cholangiography (IOC) and magnetic resonance cholangiopancreatography (MRCP) in patients with suspected CBDS. Methods: This unblinded, multicenter RCT...
9.
Mele V, Basso C, Governa V, Glaus Garzon J, Muraro M, Daster S, et al.
Cancers (Basel)
. 2022 Apr;
14(8).
PMID: 35454931
Stromal infiltration is associated with poor prognosis in human colon cancers. However, the high heterogeneity of human tumor-associated stromal cells (TASCs) hampers a clear identification of specific markers of prognostic...
10.
Walther F, Berther J, Lalos A, Ramser M, Eichelberger S, Mechera R, et al.
BMC Cancer
. 2022 Apr;
22(1):376.
PMID: 35397601
Background: Ovarian cancer (OC) is the fifth most common malignant female cancer with a high mortality, mainly because of aggressive high-grade serous carcinomas (HGSOC), but also due to absence of...